Published in AIDS Weekly, April 19th, 1999
Nevirapine and indinavir have the potential to affect each other's pharmacokinetics.
In a prospective trial, 24 HIV infected subjects on stable nucleoside or no therapy were treated with 800 mg of indinavir every eight hours ("Antiviral Effect and Pharmacokinetic Interaction between Nevirapine and Indinavir in Persons Infected with HIV Type 1," Journal of Infectious Disease, May 1999;179(5):1116-1123).
After seven days, 200 mg of nevirapine a day was added for 14 days and then...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.